Table 1.
Model | Target receptor | Ligand | Chemistry used for conjugation | Enhancement | Reference |
---|---|---|---|---|---|
Small molecule metabolites | |||||
Breast cancer | Folate receptor | Folic acid | Coupling of aminated folic acid and PLGA-NHS | 1.7-fold higher uptake | [81] |
Liver cancer | Folate receptor | Folic acid | Physical conjugation | 3.5-fold lower IC50 | [82] |
Cervical cancer | Folate receptor | Folic acid | Amino group of copolymer and folic acid | Halved tumor volume | [83] |
Bacteria | Concanavalin A | Glucose | Displacement of pentafluorophenol by β-D-glucosyloxyethylamine | 8-fold higher binding | [84] |
Bacteria | Concanavalin A | Glucose | Atom transfer radical polymerization of methacrylated-glucose monomers | 60% increased concanavalin A binding | [85] |
Peptides | |||||
Blood brain barrier | Low-density protein receptor-related protein 1 | Angiopep-2 | Maleimide terminated polymer with cysteine-terminated peptide | 3 to 4-fold higher uptake in the brain and spinal cord | [86] |
Blood brain barrier | GM1 and GT1b receptors | G23 | Maleimide functionalized polymer with cysteine bearing peptide | 4-fold increment in transcytosed polymersomes | [87] |
Lung cancer | α3β1 integrins | cyclic peptide cNGQGEQc | N-hydroxysuccinimide-functionalized polymer with amino-functionalized peptide | 3-fold lower IC50 | [88] |
Lung cancer | α3β1 integrins | cyclic peptide cNGQGEQc | N-hydroxysuccinimide-functionalized polymer with amino-functionalized peptide | Increased median survival time from 30 to 54 days | [89] |
Dendritic cells | Cellular membrane | Tat | Succinimide-terminated polymer with amino-functionalized peptide | 2 h reduction in time to obtain half-maximal fluorescent intensity; 7-fold increase maximal fluorescent intensity |
[90] |
Aptamers | |||||
Lung cancer | Epithelial cell-adhesion molecule | 19-mer EpCAM RNA aptamer | Carboxylic acid-functionalized polymer with amine-terminated aptamer | Halved tumor volume | [91] |
Protein ligands | |||||
Blood brain barrier | Low-density lipoprotein receptor family | Lactoferrin | Maleimide-functionalized polymers with sulfhydrated-lactoferrin | 2-fold increase in brain permeability surface area product | [92] |
Blood brain barrier | Transferrin receptor | Transferrin | Maleimide-functionalized polymers with sulfhydrated-transferrin | 2.3-fold increase in brain uptake | [93] |
Antibodies | |||||
Breast cancer | Human Epidermal Growth Factor Receptor-2 | Trastuzumab | Maleimide-functionalized polymer with thiol-derivatized trastuzumab | 2-fold increase in signal-to-noise ratio | [94] |
Inflamed epithelial | Endothelial cell adhesion molecules ICAM-1 | Anti-ICAM1 | Neutravidin-coated polymersomes with biotinylated antibodies | 7.5-fold increase in binding rate to inflamed versus uninflamed cells | [95] |
Blood brain barrier | Transferrin receptor | Transferrin receptor monoclonal antibodies | Maleimide-functionalized polymer with thiol-derivatized antibodies | 2.6-fold increase in accumulation in the brain | [96] |